News & Articles The latest in Phoreus & Med Technology

OLATHE, Kan., February 7, 2024 – Phoreus Biotech, an innovator in peptide nanocarriers for drug and vaccine delivery, is proud to announce the appointment of David Schaefer as its new Chief Executive Officer. With more…

Read Article

OLATHE, KS, Dec. 22, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, has announced today the results of two recent studies that demonstrate advancements in shelf-stability for mRNA vaccines and therapeutics. The…

Read Article

OLATHE, KS, Apr. 13, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, has announced today a new addition to their portfolio of proprietary nanocarrier technologies. Amphipathic Peptide Capsules (APC) offer a new way to…

Read Article

OLATHE, KS, Mar. 1, 2023 – Phoreus Biotech, a leading provider of next-generation peptide nanocarriers, announced today they’ve added a new product to their portfolio of proprietary transfection reagents. The new BAPtofect-25 for general cell…

Read Article

OLATHE, KS, Dec. 20, 2022 – Phoreus Biotechnology, a leading provider of next-generation peptide nanocarriers, announced today they have oversubscribed their $2 million dollar seed raise by more than 10 percent. Phoreus Biotech was founded…

Read Article